UCSF Medical Center Is Among Nation’s Top Hospitals for 2023-24
UCSF Medical Center has been ranked among the country’s best hospitals in adult care in U.S. News & World Report’s prestigious Best Hospitals survey.
University of California San Francisco
Give to UCSFUCSF Medical Center has been ranked among the country’s best hospitals in adult care in U.S. News & World Report’s prestigious Best Hospitals survey.
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
A new Alzheimer’s drug is expected to be approved by the Food and Drug Administration (FDA). However, the medication works best mostly for those in the earliest stages of Alzheimer’s.
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.
UCSF is helping to create the first large group of Asian American study participants to help improve Alzheimer’s disease care for the Asian community North America.
A large, collaborative study on multiple sclerosis (MS) severity found that a single gene variant is predictive of much faster neurodegeneration in MS patients.
UCSF Benioff Children’s Hospitals are recognized among the nation’s best pediatric medical centers in all 10 specialties assessed in U.S. News & World Report’s Best Children’s Hospitals 2023-24.
The advent of cheap, easy-to-use blood tests for Alzheimer’s disease has the potential to revolutionize diagnosis and treatment. But they also raise difficult questions that the field is only beginning to consider.
A new treatment approach draws on research into the unique teenage brain.
UCSF researchers developed an approach to measure an over-the-counter allergy medication’s effectiveness in repairing brain damage from multiple sclerosis (MS), making it possible to also assess future therapies for the disorder.